Bathi operasional sadurunge ngurangi amortisasi: Pharvaris (PHVS)
Pharvaris N.V. (PHVS) maintains a resilient business driven by protected capital and cost control, as evidenced by its financial EBITDA. The 0.00 level represents the current value of this curve. The company develops innovative tablets for the therapy of hereditary angioedema, targeting the orphan drug segment. Lars Nibel's strategic direction ensures a high level of scientific readiness for the future market launch of the drug.
Pharvaris (PHVS) - rincian metrik lan laporan keuangan
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas Pharvaris N.V.|PHVS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Pharvaris NV|PHVS - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Pharvaris|PHVS - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Pharvaris|Rasio cepet pharvaris.com
- data bathi lan kelipatan valuasi:
PHVS - Bathi resik perusahaan|Penghasilan resik sing dikarepake Pharvaris N.V.|PHVS - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep pharvaris.com|PHVS - Pangali PEG|Pangali EV/EBITDA Pharvaris|PHVS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Pharvaris|PHVS - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan pharvaris.com|PHVS - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Pharvaris N.V.
Analisis kabeh metrik perusahaan:Pharvaris Pharma, PHVS
The monetization of innovative tablets for the treatment of HAE forms the primary cash flow for Pharvaris N.V. (PHVS). This figure is calculated by excluding depreciation, taxes, and interest expenses from operating profit. The metric reflects the business's actual ability to generate cash, independent of accounting conventions. The trend in annual EBITDA serves as an indicator of the company's fundamental stability. Analysis of this chart allows for an assessment of the drug's commercialization efficiency regardless of the debt load.
Karo sapa Pharvaris N.V. saingan
Pendapatan operasional sadurunge ngurangi amortisasi argenx BVBA (ARGX)|BNTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Abivax S.A. (ABVX) - Bathi operasional sadurunge ngurangi amortisasi|ADMA Biologics, Inc. (ADMA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Protagonist Therapeutics, Inc.|Bathi operasional sadurunge ngurangi amortisasi IMVT|Bathi operasional EBITDA Kiniksa Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Grifols, S.A. (GRFS)|adaptivebiotech.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Bathi sadurunge bunga, pajak, lan amortisasi|BCRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi VERA|DNTH: Bathi operasional EBITDA|AbCellera - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|TRML (Tourmaline Bio) - Bathi operasional EBITDA|Bathi operasional EBITDA Precigen Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pharming (PHAR)|NKTR (Nektar Corp) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Upstream Bio Inc - Bathi operasional sadurunge ngurangi amortisasi|zenasbio.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Immunome - Bathi operasional EBITDA|GOSS - Bathi operasional EBITDA|KalVista Pharmaceuticals Inc (KALV) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Septerna Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|PVLA (Pieris Pharmaceuticals) - Bathi operasional EBITDA|savarapharma.com (SVRA) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Rigel Pharmaceuticals, Inc. (RIGL)|Pendapatan operasional sadurunge ngurangi amortisasi AnaptysBio Inc|Astria Pharma - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ENGN|RAPT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|JBIO (Aerovate Therapeutics Inc) - Bathi operasional sadurunge amortisasi|ACRS (Aclaris Therapeutics, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|KYTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi TLSA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CABA|Bathi operasional sadurunge ngurangi amortisasi VTYX (Ventyx Biosciences)|Pendapatan operasional sadurunge ngurangi amortisasi theratech.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Agenus Inc - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CLYM (Climb Bio, Inc)|ZURA (Zura Bio) - Bathi operasional sadurunge ngurangi amortisasi|ATYR (atyrpharma.com) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adagene Inc|Ikena Oncology, Inc. (IMA) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Shattuck Labs, Inc. (STTK)|EQ: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA CNTB (Connect Biopharma Holdings Limited)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IMUX|Atara Biotherapeutics Inc - Bathi operasional EBITDA|IFRX - Bathi operasional EBITDA|X4 Pharma (XFOR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Adicet Bio, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Celularity Inc|Bathi operasional sadurunge ngurangi amortisasi inmunebio.com (INMB)|Bathi operasional EBITDA BRNS|Bathi operasional EBITDA Kezar Life Sciences Inc. (KZR)|SAB Biotherapeutics, Inc - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi AKTX|Enlivex Therapeutics, Ltd. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Q32 Bio Inc. QTTB|GeoVax (GOVX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Edesa Biotech Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi iBio Corp|Bathi operasional sadurunge ngurangi amortisasi Carisma Tx (CARM)|Bathi operasional sadurunge ngurangi amortisasi XTLB (XTL Biopharmaceuticals)|Bathi operasional EBITDA boltbio.com (BOLT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi HCW Biologics HCWB|APVO: Bathi operasional sadurunge amortisasi|AIM ImmunoTech Inc. - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Aditxt|GRI Bio, Inc. (GRI) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi XRTX (xortx.com)|HIND (Vyome Holdings) - Bathi operasional EBITDA|REVB: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA INDP|Bathi operasional EBITDA BiondVax Pharmaceuticals (SCNI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CalciMedica CALI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi AFMD|ALLK: Bathi operasional sadurunge ngurangi amortisasi|HOOK: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IGMS: Bathi operasional EBITDA|iTeos Pharma (ITOS) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ocean Biomedical, Inc.|TCBP: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA THRD
